Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Common Stock Net 2010-2025 | MKKGY

Merck common stock net from 2010 to 2025. Common stock net can be defined as the value of common equity ownership.
  • Merck common stock net for the quarter ending March 31, 2025 was $0.595B, a 2.97% decline year-over-year.
  • Merck common stock net for 2024 was $0.611B, a 0.02% decline from 2023.
  • Merck common stock net for 2023 was $0.612B, a 2.72% increase from 2022.
  • Merck common stock net for 2022 was $0.595B, a 10.95% decline from 2021.
  
Merck Annual Common Stock Net
(Millions of US $)
2024 $611
2023 $612
2022 $595
2021 $668
2020 $645
2019 $2,850
2018 $667
2017 $639
2016 $625
2015 $627
2014 $751
2013 $751
2012 $727
2011 $787
2010 $0
2009 $0
Merck Quarterly Common Stock Net
(Millions of US $)
2025-03-31 $595
2024-12-31 $611
2024-09-30 $621
2024-06-30 $608
2024-03-31 $613
2023-12-31 $612
2023-09-30 $615
2023-06-30 $616
2023-03-31 $606
2022-12-31 $595
2022-09-30 $569
2022-06-30 $601
2022-03-31 $634
2021-12-31 $668
2021-09-30 $666
2021-06-30 $681
2021-03-31 $681
2020-12-31 $645
2020-09-30 $660
2020-06-30 $622
2020-03-31 $623
2019-12-31 $2,850
2019-09-30 $628
2019-06-30 $2,615
2019-03-31 $642
2018-12-31 $667
2018-09-30 $657
2018-06-30 $674
2018-03-31 $694
2017-12-31 $639
2017-09-30 $664
2017-06-30 $621
2017-03-31 $602
2016-12-31 $625
2016-09-30 $631
2016-06-30 $638
2016-03-31 $623
2015-12-31 $627
2015-09-30 $629
2015-06-30 $625
2015-03-31 $638
2014-12-31 $751
2014-09-30 $750
2014-06-30 $775
2014-03-31 $775
2013-12-31 $751
2013-09-30 $749
2013-06-30 $738
2013-03-31 $747
2012-12-31 $727
2012-09-30 $707
2012-06-30 $726
2012-03-31
2011-12-31 $787
2011-09-30
2011-06-30 $813
2011-03-31
2010-12-31
2010-09-30 $729
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $16.874B $22.569B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $68.750B 26.44
Zoetis (ZTS) United States $66.376B 24.08
Takeda Pharmaceutical (TAK) Japan $46.552B 9.50
Daiichi Sankyo, - (DSNKY) Japan $46.222B 23.69
BeOne Medicines - (ONC) Switzerland $31.576B 0.00
Sandoz Group AG (SDZNY) Switzerland $26.096B 0.00
Summit Therapeutics (SMMT) United States $19.080B 0.00
Shionogi (SGIOY) Japan $15.432B 15.46
United Therapeutics (UTHR) United States $13.595B 11.76
Neurocrine Biosciences (NBIX) United States $12.784B 38.13
Orion OYJ (ORINY) Finland $10.848B 26.14
IPSEN (IPSEY) France $10.440B 0.00
Madrigal Pharmaceuticals (MDGL) United States $7.971B 0.00
Corcept Therapeutics (CORT) United States $7.754B 65.12
Grifols, S.A (GRFS) Spain $7.288B 0.00
Stevanato Group S.p.A (STVN) Italy $6.611B 38.98
Ionis Pharmaceuticals (IONS) United States $6.600B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.317B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.141B 17.65
Soleno Therapeutics (SLNO) United States $4.430B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.827B 13.46
NewAmsterdam Pharma (NAMS) Netherlands $2.807B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.682B 0.00
Hypermarcas (HYPMY) Brazil $2.579B 19.39
Catalyst Pharmaceuticals (CPRX) United States $2.489B 8.34
Centessa Pharmaceuticals (CNTA) United Kingdom $2.286B 0.00
Ocular Therapeutix (OCUL) United States $2.171B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.753B 0.00
Dyne Therapeutics (DYN) United States $1.653B 0.00
ARS Pharmaceuticals (SPRY) United States $1.636B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.490B 22.20
Guardian Pharmacy Services (GRDN) United States $1.432B 0.00
Evotec AG (EVO) Germany $1.353B 0.00
Ardelyx (ARDX) United States $1.350B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.296B 0.00
Harrow (HROW) United States $1.289B 0.00
Collegium Pharmaceutical (COLL) United States $1.193B 6.52
Xeris Biopharma Holdings (XERS) United States $1.179B 0.00
Cronos Group (CRON) Canada $0.983B 0.00
Enliven Therapeutics (ELVN) United States $0.927B 0.00
Akebia Therapeutics (AKBA) United States $0.880B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.731B 0.00
Siga Technologies (SIGA) United States $0.666B 8.23
ProKidney (PROK) United States $0.656B 0.00
Zevra Therapeutics (ZVRA) United States $0.643B 0.00
Organogenesis (ORGO) United States $0.620B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.619B 6.38
KalVista Pharmaceuticals (KALV) United States $0.612B 0.00
Elite Pharmaceuticals (ELTP) United States $0.608B 0.00
Bioventus (BVS) United States $0.600B 14.62
Theravance Biopharma (TBPH) United States $0.596B 49.67
Relay Therapeutics (RLAY) United States $0.578B 0.00
Xencor (XNCR) United States $0.553B 0.00
Tourmaline Bio (TRML) United States $0.552B 0.00
USANA Health Sciences (USNA) United States $0.549B 11.26
Tonix Pharmaceuticals Holding (TNXP) United States $0.524B 0.00
Oruka Therapeutics (ORKA) United States $0.522B 0.00
Savara (SVRA) United States $0.446B 0.00
Aquestive Therapeutics (AQST) United States $0.377B 0.00
Esperion Therapeutics (ESPR) United States $0.355B 0.00
Nanobiotix S.A (NBTX) France $0.355B 0.00
Aldeyra Therapeutics (ALDX) United States $0.321B 0.00
Larimar Therapeutics (LRMR) United States $0.306B 0.00
Altimmune (ALT) United States $0.294B 0.00
Nektar Therapeutics (NKTR) United States $0.293B 0.00
4D Molecular Therapeutics (FDMT) United States $0.287B 0.00
Nature's Sunshine Products (NATR) United States $0.287B 18.71
AleAnna (ANNA) United States $0.287B 0.00
OmniAb (OABI) United States $0.239B 0.00
Galectin Therapeutics (GALT) United States $0.239B 0.00
MediWound (MDWD) Israel $0.203B 0.00
Heron Therapeutics (HRTX) United States $0.201B 0.00
Journey Medical (DERM) United States $0.199B 0.00
China SXT Pharmaceuticals (SXTC) China $0.181B 0.00
Aclaris Therapeutics (ACRS) United States $0.178B 0.00
Innate Pharma SA (IPHYF) France $0.173B 0.00
Profound Medical (PROF) Canada $0.167B 0.00
Lyell Immunopharma (LYEL) United States $0.163B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.159B 24.56
MEI Pharma (MEIP) United States $0.155B 0.00
Lexeo Therapeutics (LXEO) United States $0.155B 0.00
Korro Bio (KRRO) United States $0.150B 0.00
Avita Medical (RCEL) United States $0.147B 0.00
Inhibikase Therapeutics (IKT) United States $0.130B 0.00
Avalo Therapeutics (AVTX) United States $0.123B 0.00
Protara Therapeutics (TARA) United States $0.118B 0.00
Liminatus Pharma (LIMN) United States $0.113B 0.00
Cassava Sciences (SAVA) United States $0.112B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.110B 0.00
Dominari Holdings (DOMH) United States $0.103B 0.00
Cardiol Therapeutics (CRDL) Canada $0.093B 0.00
Surrozen (SRZN) United States $0.091B 0.00
Champions Oncology (CSBR) United States $0.090B 20.41
VAXART, INC (VXRT) United States $0.087B 0.00
ESSA Pharma (EPIX) Canada $0.085B 0.00
Achieve Life Sciences (ACHV) Canada $0.085B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
Assertio Holdings (ASRT) United States $0.079B 0.00
BioNxt Solutions (BNXTF) Canada $0.079B 0.00
Nutriband (NTRB) United States $0.076B 0.00
PMV Pharmaceuticals (PMVP) United States $0.075B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Metagenomi (MGX) United States $0.070B 0.00
Inotiv (NOTV) United States $0.069B 0.00
Pyxis Oncology (PYXS) United States $0.064B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.063B 0.00
Context Therapeutics (CNTX) United States $0.061B 0.00
DURECT (DRRX) United States $0.059B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Rafael Holdings (RFL) United States $0.058B 0.00
PolyPid (PYPD) Israel $0.054B 0.00
Unicycive Therapeutics (UNCY) United States $0.054B 0.00
Wellgistics Health (WGRX) United States $0.054B 0.00
Fractyl Health (GUTS) United States $0.048B 0.00
Prelude Therapeutics (PRLD) United States $0.047B 0.00
Telomir Pharmaceuticals (TELO) United States $0.046B 0.00
Gain Therapeutics (GANX) United States $0.046B 0.00
Century Therapeutics (IPSC) United States $0.045B 0.00
Plus Therapeutics (PSTV) United States $0.044B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.044B 26.45
NRx Pharmaceuticals (NRXP) United States $0.041B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
Tempest Therapeutics (TPST) United States $0.039B 0.00
FibroGen (FGEN) United States $0.037B 0.00
Klotho Neurosciences (KLTO) United States $0.037B 0.00
Enlivex Therapeutics (ENLV) Israel $0.037B 0.00
Jupiter Neurosciences (JUNS) United States $0.037B 0.00
Karyopharm Therapeutics (KPTI) United States $0.035B 0.00
Iterum Therapeutics (ITRM) Ireland $0.035B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
Scienture Holdings (SCNX) United States $0.034B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
Mural Oncology (MURA) Ireland $0.029B 0.00
Vivos Therapeutics (VVOS) United States $0.028B 0.00
Natural Alternatives (NAII) United States $0.024B 0.00
Cosmos Health (COSM) United States $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.022B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.022B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
Citius Pharmaceuticals (CTXR) United States $0.014B 0.00
Ainos (AIMD) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Incannex Healthcare (IXHL) Australia $0.012B 0.00
Carisma Therapeutics (CARM) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
TransCode Therapeutics (RNAZ) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
VYNE Therapeutics (VYNE) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
Jaguar Animal Health (JAGX) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
BioVie (BIVI) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 12.83
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 2.15
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00